Amanda Van de Poël - Concepedia

Author

Amanda Van de Poël

Also Known As

A. Poel, Amanda Van De Poël, Amanda Van de Poël

Publications

194

Citations

H-Index

Concepts

All Affiliations

Amanda Van de Poël is an author at CHDI Foundation specializing in pharmacotherapy, medicine, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	104
2	Natural Sciences	1	1	80
3	Biochemistry	1	1	80
4	Cell Biology	1	1	24
5	Molecular Biology	1	1	24

Amanda Van de Poël

Publications

188

Citations

H-Index

Page 1

	Year	Citations
Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986) Kevin Doyle, Hans Lönn, Helena Käck, Journal of Medicinal Chemistry Drug TargetClinical CandidatePharmacotherapyOxazepane AmidoacetonitrilePharmaceutical Chemistry	2016	80
VACM-1, a cullin gene family member, regulates cellular signaling Maria A. Burnatowska-Hledin, Ping Zhao, Byron E. Capps, American Journal of Physiology-Cell Physiology	2000	40
VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways Christa Van Dort, Ping Zhao, K. Parmelee, American Journal of Physiology-Cell Physiology	2003	31
Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington’s Disease Models Leticia Toledo‐Sherman, Perla Breccia, Roger Cachope, Journal of Medicinal Chemistry GeneticsMolecular BiologyPharmacotherapyDisease Gene IdentificationHd Animal Models	2019	24
Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington’s Disease Amanda Van de Poël, Leticia Toledo‐Sherman, Perla Breccia, Journal of Medicinal Chemistry	2021	13

Page 1